Can you keep the weight off after stopping Wegovy?

The myth: stopping Wegovy simply locks in your results

This is the question our prescribers hear most weeks, and the honest answer runs counter to what many people hope. There is a widespread belief that Wegovy's job is to kickstart weight loss and that the body then holds the new lower weight independently. The trial data tell a different story. In the STEP 1 extension study, published in the New England Journal of Medicine, participants who stopped semaglutide 2.4mg after 68 weeks regained on average about two-thirds of their lost weight within 52 weeks of stopping. Importantly, cardiometabolic improvements (reductions in blood pressure, blood glucose and waist circumference) also largely reversed over the same period.

Why does this happen? Semaglutide works by activating GLP-1 receptors that regulate appetite and slow gastric emptying. Those signals are present while you are taking the medicine. When the medicine clears your system, the signals fade. Obesity is a chronic condition with powerful biological drivers; removing the treatment does not change those underlying drivers. This is not a flaw in the medicine, it is how chronic-condition management works. You can read more about how the medicine functions on our Wegovy overview page.

None of this means effort during treatment is wasted. People who used the reduced-appetite window to genuinely restructure their eating patterns, build consistent activity habits and address psychological relationships with food did retain more of their results than those who relied on the medicine alone, and our guide to keeping weight off after Wegovy sets out the practical steps that appear to make the most difference. The medicine buys time and removes a substantial biological barrier; what you do with that time is what shapes the long-term picture.

What actually helps you keep more of the weight off

The honest framing here is maintenance, not permanence. Most people who stop Wegovy will regain some weight; the question is how much. Several factors appear consistently in the evidence and in clinical practice.

Protein and muscle mass. Rapid weight loss can reduce lean muscle alongside fat. People who prioritised dietary protein and included resistance exercise during treatment tended to lose proportionally more fat than muscle, which matters because muscle is metabolically active tissue that supports energy expenditure. The NHS healthy weight guidance recommends maintaining activity levels as a core part of weight management, not a temporary addition.

Behavioural patterns established during treatment. The reduced-hunger state that Wegovy creates is an opportunity to rehearse smaller portions, slower eating, better food choices and a more regular pattern of meals. Those habits do not disappear automatically when the medicine stops, but they require active reinforcement. People who treated the treatment period as a training phase fared better than those who reverted to previous patterns the moment appetite returned.

Planning the stop with your prescriber. An unplanned stop (whether due to supply, cost or side effects) leaves little room to put a maintenance strategy in place. If you are thinking about stopping, the right conversation to have first is with the clinical team managing your treatment. You can also explore how quickly weight returns after stopping semaglutide, the timeline is not immediate, which gives a window to act.

NHS and private options if you want to continue treatment

For many people, the evidence points to Wegovy being most effective as a long-term or ongoing medicine rather than a fixed-course one. NICE's appraisal of semaglutide (TA875) recommends it for use within specialist NHS weight management services for a maximum of two years, after which NHS provision stops, even if the weight loss has been significant. That two-year cap is an NHS commissioning decision, not a safety limit.

In private practice, continued prescribing beyond two years is clinically possible for eligible adults and may be appropriate depending on individual circumstances. The cost of ongoing Wegovy treatment is a real consideration for many people, and it is worth understanding what that looks like before you reach a decision point. Our FAQs page covers common questions about continuing or pausing treatment.

If you have been trying to understand how to keep weight off after semaglutide in a more structured way, that page covers practical strategies in more detail. There is also emerging clinical interest in using lower maintenance doses rather than stopping entirely, a question currently best explored with a prescriber rather than from general reading.

Making a plan before you stop

The single most useful thing anyone can do before stopping Wegovy is to have a specific conversation with their prescriber about what comes next. That conversation should cover: what weight-related health conditions improved during treatment and what might happen to them; what lifestyle changes are genuinely embedded versus which ones were medicine-assisted; and whether tapering, pausing, or switching to a different approach makes clinical sense.

Stopping without that conversation is rarely the right move. The same applies if you are considering switching to a different treatment. For context on what the alternatives look like, our weight-loss treatments overview sets out what is currently licensed in the UK. And if you are thinking about getting more from treatment while you are still taking it, that is often the better question, making the most of the window the medicine opens is more productive than planning an exit before results are consolidated.

If you have not yet started treatment and want to understand your options, check your eligibility with our prescribers, there is no obligation, and the consultation is free.